Malignant Brain Neoplasm — Trials

Malignant Brain Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

636 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 193
Recruiting: 112
Ph III recruiting: 4
Growth YoY: +9.4%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (99)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03149575	VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM(STAR-3)	terminated	Phase 3	2	DelMar Pharmaceuticals, Inc.INDUSTRY	1	Sep 4, 2025	clinicaltrials
NCT01987596	Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer	terminated	Phase 3	23	Barbara Ann Karmanos Cancer InstituteOTHER	1	Oct 29, 2020